![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Deeg H J, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anaemia. Blood 1998; 91: 3637–3645
- Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bonemarrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group forBlood and Marrow Transplantation. Haematologica 2007; 92: 11–18
- Marsh J CW, Ball S E, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. British Committee for Standards in Haematology, London 2007
- Marsh J CW. Treatment of acquired aplastic anaemia. Haematologica 2007; 92: 2–5
- Salooja N, Szydlo R M, Socie G, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001; 358: 271–276
- Sanders J E, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052
- Tichelli A, Socie G, Marsh J, et al. Outcome of pregnancy anddisease course among women with aplastic anemia treated with immunosuppression. Annals of Internal Medicine 2002; 137: 164–172
- Young N S, Calodo R T, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108: 2509–2519